NDC 0338-9632-01 - Zosyn
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-9632
- Requested NDC
- 0338-9632-01
- Package NDCs from labels
- 0338-9632-01, 0338-9632-24
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2026-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zosyn - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2026-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-9632-01 | Zosyn | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 6 | |
| 0338-9632-24 | Zosyn | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-9632-01 | ML - Milliliter | 0338-9632 | ca93780b-b5d8-4a16-99c2-9deb9652eea6 | 1 | 2023-05-05 |
| 0338-9632-24 | ML - Milliliter | 0338-9632 | 5b08da5a-ee9a-4754-928a-b2decf362dd2 | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | ada63d44-3b37-b65d-e053-2a95a90aa088 | 2023-05-03 | Warnings, Adverse reactions | LX22YL083G |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Zosyn in Galaxy Containers | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623 | 2023-03-15 | Warnings, Adverse reactions | NDA050750 1659134 1659137 1659151 1659131 1659149 1659139 M98T69Q7HP UXA545ABTT |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | LX22YL083G |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Acidum Muriaticum | ACIDUM MURIATICUM | Hahnemann Laboratories, INC. | f2aad04c-5151-6cab-e053-2a95a90ad3a7 | 2023-01-19 | QTT17582CB | |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | International Medication Systems, Limited | fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d | 2022-12-20 | Warnings, Adverse reactions | LX22YL083G |
| 25% Dextrose Infant | 25% DEXTROSE INFANT | HF Acquisition Co. LLC, DBA Health First | 73d04839-a2bb-65dd-e053-2991aa0a82ca | 2022-12-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 9c80dfee-8923-4d1f-85b0-98bd68b94212 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 50603082-bce5-49eb-9737-e04239cfb695 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | LX22YL083G | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | LX22YL083G | |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | dc8208ea-a632-4291-a90b-2eba9a33bb40 | 2022-10-27 | Warnings, Adverse reactions | 1659137 1659131 1659149 M98T69Q7HP UXA545ABTT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.